BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 27290706)

  • 1. Evaluation of dementia rating scales in Parkinson's disease dementia.
    Harvey PD; Ferris SH; Cummings JL; Wesnes KA; Hsu C; Lane RM; Tekin S
    Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):142-8. PubMed ID: 19359706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive profile of the earliest stage of dementia in Parkinson's disease.
    Petrova M; Raycheva M; Traykov L
    Am J Alzheimers Dis Other Demen; 2012 Dec; 27(8):614-9. PubMed ID: 22992299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns of short-term memory deficit in Alzheimer's disease, Parkinson's disease and subjective cognitive impairment.
    Zokaei N; Sillence A; Kienast A; Drew D; Plant O; Slavkova E; Manohar SG; Husain M
    Cortex; 2020 Nov; 132():41-50. PubMed ID: 32919108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Cerebral White Matter Lesion Burdens between Parkinson's Disease with and without Dementia.
    Choi SA; Evidente VG; Caviness JN
    J Mov Disord; 2010 May; 3(1):6-10. PubMed ID: 24868371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-Carbon Metabolism in Alzheimer's Disease and Parkinson's Disease Brain Tissue.
    Kalecký K; Ashcraft P; Bottiglieri T
    Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vision-fair neuropsychological assessment in normal aging, Parkinson's disease and Alzheimer's disease.
    Toner CK; Reese BE; Neargarder S; Riedel TM; Gilmore GC; Cronin-Golomb A
    Psychol Aging; 2012 Sep; 27(3):785-90. PubMed ID: 22201330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia with Parkinson disease: Clinical diagnosis, neuropsychological aspects and treatment.
    Otero JL
    Dement Neuropsychol; 2008; 2(4):261-266. PubMed ID: 29213582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed recall memory impairment in patients with Parkinson's disease.
    Schelp AO; Mendes-Chiloff CL; Paduan VC; Corrente JE; de Lima FD; Marchette JCN; Luvizuto GJ; Bazan R
    Dement Neuropsychol; 2016; 10(3):204-209. PubMed ID: 29213456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.
    Watson GS; Cholerton BA; Gross RG; Weintraub D; Zabetian CP; Trojanowski JQ; Montine TJ; Siderowf A; Leverenz JB
    Alzheimers Dement; 2013 Sep; 9(5):609-14. PubMed ID: 23164549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting glucose variability and risk of dementia in Parkinson's disease: a 9-year longitudinal follow-up study of a nationwide cohort.
    Kang SH; Choi Y; Chung SJ; Moon SJ; Kim CK; Kim JH; Oh K; Yoon JS; Seo SW; Cho GJ; Koh SB
    Front Aging Neurosci; 2023; 15():1292524. PubMed ID: 38235038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of imminent collisions by drivers with Alzheimer's disease and Parkinson's disease: a preliminary study.
    Vaux LM; Ni R; Rizzo M; Uc EY; Andersen GJ
    Accid Anal Prev; 2010 May; 42(3):852-8. PubMed ID: 20380912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF pulsations measured in Parkinson's disease patients using EPI-based fMRI data.
    Kim JH; Kim S; Im JG; Chung SJ; Lee PH; Jeong Y; Park SH
    Front Aging Neurosci; 2024; 16():1369522. PubMed ID: 38737587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive fluctuations as a challenge for the assessment of decision-making capacity in patients with dementia.
    Trachsel M; Hermann H; Biller-Andorno N
    Am J Alzheimers Dis Other Demen; 2015 Jun; 30(4):360-3. PubMed ID: 24946784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Branched-chain amino acids and the risks of dementia, Alzheimer's disease, and Parkinson's disease.
    Fu Y; Wang Y; Ren H; Guo X; Han L
    Front Aging Neurosci; 2024; 16():1369493. PubMed ID: 38659706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effectiveness of Reality Orientation Therapy in the Treatment of Parkinson Disease Dementia.
    Camargo CHF; Ladeira MA; Serpa RA; Jobbins VA; Filho CRP; Welling LC; Teive HAG
    Am J Alzheimers Dis Other Demen; 2018 Oct; 34(2):1533317518802461. PubMed ID: 30286613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of naming impairment among patients with Parkinson's disease without dementia, Parkinson's disease dementia and Alzheimer's disease].
    Gui XH; Wang LP; Wu CL; Sun XF
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(21):1664-7. PubMed ID: 27290706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The characteristics of Parkinson's disease with dementia and Alzheimer's disease with impaired cognitive function].
    Wang LP; Sun XF; Wu CL; Shao JS; Zhong JJ; Guo QH
    Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1035-8. PubMed ID: 21211363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everyday action impairment in Parkinson's disease dementia.
    Giovannetti T; Britnell P; Brennan L; Siderowf A; Grossman M; Libon DJ; Bettcher BM; Rouzard F; Eppig J; Seidel GA
    J Int Neuropsychol Soc; 2012 Sep; 18(5):787-98. PubMed ID: 22621995
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.